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Annexin A2, A7, and A11 expression in head and
neck squamous cell carcinoma*
Aim: To investigate annexin A2 (ANXA2), annexin A7 (ANXA7), and annexin A11 (ANXA11)
expression in head and neck squamous cell carcinoma (HNSCC). Although overexpression of
ANXA2 has been reported in HNSCC, there are no studies on ANXA7 or ANXA11 in the same
region.
Materials and Methods: ANXA2, ANXA7, and ANXA11 were immunohistochemically studied in
paraffin-embedded sections obtained from 43 patients with HNSCC.
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Results: ANXA2 and ANXA11 expression was more intense in the tumor areas in HNSCC (P = 0
for ANXA2, P = 0.05 for ANXA11). Both the tumors and normal mucosae showed membranous
staining for ANXA7 and ANXA2, while there was mostly nuclear staining for ANXA11. Another
important finding was that tumor differentiation decreased as ANXA2 expression intensity (P =
0.001) and staining score (P = 0) decreased. There was a significant relationship between ANXA7
expression and tumoral growth pattern (P = 0.001).
Conclusions: This is the first study to show ANXA7 and ANXA11 expression in HNSCC. ANXA2
staining severity and score were related to the degree of tumor differentiation in HNSCC. The
membranous staining pattern decreased with decreasing differentiation for ANXA7. There was a
linear relationship between the expression of ANXA2 and ANXA7.
Key words: Annexin A2, annexin A7, annexin A11, squamous cell carcinoma, head and neck
neoplasms

Baş boyun bölgesi skuamöz hücreli karsinomunda anneksin A2, A7 ve
A11 in ekspresyonları
Amaç: Bu çalışmanın amacı baş boyun bölgesi skuamöz hücreli karsinomunda (BBSHK) anneksin
A2 (ANXA2), anneksin A7 (ANXA7) ve anneksin A11 (ANXA11) in ekspresyonlarını araştırmaktır.
Anneksin A2 nin BBSHK larında ekspresyonuna ilişkin çalışma bulunurken, bu bölge
karsinomlarında anneksin A7 ve anneksin A11 ile ilgili data yoktur.
Yöntem ve Gereç: ANXA2, ANXA7 ve ANXA11, 43 BBSHK lu hastanın parafine gömülü
materyallerinden elde edilen kesitlere immünohistokimyasal olarak uygulandı.
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Bulgular: BBSHK larında ANXA2 ve ANXA11 ile tümörde boyanma daha şiddetli bulundu
(ANXA2 için P = 0 ve ANXA11 için P = 0,05). ANXA7 ve ANXA2 hem tümör hem de normal
mukozada membranöz paternde boyanırken, ANXA11 de nükleer patern hakimdi. ANXA2 nin
ekspresyon şiddeti (P = 0,001) ve yaygınlığı (P = 0) azaldıkça tümörde diferansiyasyonun azalması
saptanan diğer önemli bulgulardı. Ayrıca ANXA7 ekspresyonu ile BBSHK larının büyüme paterni
arasında anlamlı bir ilişki izlendi (P = 0,001).
Sonuç: İlk defa bu çalışmada ANXA7 ve ANXA11 in BBSHK larında eksprese edildiği gösterilmiştir.
ANXA2 nin boyanma şiddetinin ve yaygınlığının BBSHK larında tümörün diferansiyasyon derecesi
ile ilişkili olduğu gözlenmiştir. ANXA2 ile ANXA7 ekspresyonları arasında doğrusal bir ilişki
saptanmıştır.
Anahtar sözcükler: Anneksin A2, anneksin A7, anneksin A11, skuamöz hücreli karsinom, başboyun neoplazileri
* The source of support is the Dışkapı Yıldırım Beyazıt Training and Research Hospital Commission
of Support of Scientific Studies.
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Introduction

Materials and methods

Annexins are a protein family sensitive to
phosphorylation and dephosphorylation that can
bind phospholipids in the presence of Ca++ ions and
can suppress phospholipase A2. Annexin is composed
of a 70-amino acid domain that consists of 5 alpha
helices bound together with short bonds. Each
member of the ANX protein family contains 4
annexin repeats in a characteristic manner (1).

The present study included 43 patients diagnosed
with and treated for HNSCC at our hospital between
2005 and 2008. The study conformed with the
principles of the Helsinki Declaration and received
ethics committee approval.

Human annexins belong to the A subfamily of
vertebrate annexins and have 12 members. They are
shown with the ANX symbol, and A1-A11 and A13
suffixes. Annexin A12 has not yet been defined.
Annexins take part in such cellular events as
protection of the cytoskeleton and its interaction with
the extracellular matrix, growth and tissue
differentiation, inflammation, and clotting, thanks to
their relationships with other proteins and their role
in signal transduction (2). Various annexins have been
shown to play a role in carcinogenesis stages, such as
cell line transformation (3), tumor progression (4),
and metastasis (5,6). This indicates that annexins may
play a role in tumor suppression.
Hayes et al. reported in a review of
annexinopathies that annexins show both decreased
and increased expression in various cancers (but not
in the same cancer), and that it is therefore not
possible to place them simply in the tumor suppressor
gene or oncogene class (7). Musunoor et al. reviewed
the potential role of annexins in tumor development
and progression (8). They reported a potential role for
annexins in tumorigenesis. Changes in annexin
expression are associated with some tumor types and
diseases (7). Annexins may therefore be useful as
biomarkers for clinical usage.
ANXA2 has been found in the normal epithelium
of the upper respiratory and digestive systems, and in
head and neck carcinomas (9,10); however, there are
no data on the expression of ANXA7 and ANXA11
in head and neck carcinomas. We compared the
expression of ANXA7 and ANXA11 in head and neck
region squamous cell carcinoma (HNSCC) with that
in normal epithelium using immunohistochemical
methods in this study, and evaluated their relationship
with prognostic parameters, such as degree of
differentiation, lymph node metastasis, and growth
pattern.
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Histopathological evaluations were performed by
evaluating 3-5-μm hematoxylin-eosin stained archive
slides that were prepared from paraffin blocks
according to routine procedures following fixation
with 10% buffered formalin. Distribution according
to tumor localization in the patients was as follows:
21 (48.8%) larynx, 11 (25.6%) lower lip, 6 (14%) oral
cavity, 4 (9.3%) the tongue, and 1 (2.3%) the tonsils.
Mean age of the patients was 57.5 years; 40 (93%)
patients were male and 3 (7%) were female. Mean
tumor diameter was 2.87 cm (range: 1-7 cm). All the
patients had a history of smoking and alcohol use.
None of the patients received radiotherapy or
chemotherapy before surgery.
All patients contained normal mucosa in addition
to the tumor. Histological typing and grading of the
tumors were performed according to the World
Health Organization (WHO) classification (11), and
the tumors were separated into 3 groups: welldifferentiated, moderately differentiated, and poorly
differentiated. Histopathological analysis of the cases
revealed 25 (58.1%) well-differentiated, 15 (34.9%)
moderately differentiated, and 3 (7%) poorly
differentiated squamous cell carcinomas. The tumor
was infiltrative in 11 (25.58%) cases and had an
expansile growth pattern in 32 (74.42%) cases. Lymph
node metastasis was present (N1-3) in 9 (20.9%) cases
and absent (N0) in 34 (79.1%).
Immunohistochemical staining procedure
Annexin 7
1. A paraffin block that best reflected each tumor's
general characteristics and also contained normal
mucosal epithelium was selected for each case.
Sections 3-5-μm thick obtained from paraffin
blocks were placed on slides with polylysine.
2. The sections were deparaffinized and then
dehydrated.
3. The sections were placed inside a container with
10 mM citrate buffer solution (pH = 6) and
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microwaved twice for 5 min at high temperatures,
The sections were then cooled at room
temperature for 20 min.
4. The sections were then placed in a humidifier and
were incubated for 15 min after drops of 0.3%
hydrogen peroxide (H2O2) were added to remove
endogenous peroxidase activity in the tissues.
5. Large Volume Ultra V Block (Lab Vision, Cat; TA125-UB) solution was placed on the sections to
prevent nonspecific staining and they were
incubated for 5 min.
6. A primary antibody (ANXA7, Santa Cruz,
monoclonal Mouse) was added and incubation
was performed at 1/100 dilution for 1 h at room
temperature (18-25 °C).
7. Secondary antibody Biotinylated Goat AntiPolivalent (Lab. Vision, Cat TP-125-BN) was
added and incubated for 20 min. Drops of Large
Volume Streptavidin Peroxidase (Lab Vision Cat:
TS- 125-HR) were added as a marker and the
sections were incubated for 20 min.
8. 3.3’Diaminobenzidine (DAB) solution was used
for chromogen application for 10 min.
9. Counterstaining was accomplished with Mayer
hematoxylin, while Large Volume Ultra Mount
Plus was used for covering.
Annexin 2 and 11
The same procedures used for ANXA 7 were
repeated, except the solution was not placed in a
microwave oven when going through the PBS
solution following dehydration in absolute alcohol
after the incubation stage, and incubation was for 10
min instead of 15 min after the 0.3% hydrogen
peroxide drops were added. We again used 1/100
diluted ANXA2 and ANXA11 (Santa Cruz,
monoclonal Mouse) drops as primary antibody and
incubated for 1 h at room temperature (18-25 °C).
Immunoreactivity evaluation
We used oral mucosa for Annexin 2, the adrenal
gland for Annexin 7, and epididymis tissue sections
for Annexin 11 as positive a control in
immunohistochemical studies. Membranous staining
for Annexin 2, membranous, cytoplasmic, and
nuclear staining for Annexin 7, and membranous,
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cytoplasmic, and nuclear staining for Annexin 11 in
control tissues were accepted as positive.
Immunohistochemical staining was evaluated in the
non-neoplastic mucosal epithelium (squamous
epithelium) and areas of least tumor differentiation
using 10×, 20×, and 40× oculars. Staining intensity
was graded as follows: ‘−‘ for no staining; ‘+’ for light
yellow granules; ‘++’ for light yellow-brown granules;
‘+++’ for dark yellow-brown dense granules. Staining
score was as follows: 100 cells were counted in 5
different fields under 40× magnification and then
averaged. A distribution under 5% was ‘−’ (negative),
5% - 25% ‘+’, 25% -75% ‘++’, and over 75% ‘+++’.
Statistical evaluation
Statistical analysis was performed using SPSS
(Statistical Package for the Social Sciences) v.11.0 for
Windows.
Clinicopathological
and
immunohistochemical data were evaluated with the
generalized form of Fisher’s chi square test for
multiple cell tables and marginal homogeneity
(McNemar). A P value less than 0.05 was considered
significant.
Results
Expression of Annexin 2 in normal epithelium
and tumors
There was no difference in the ANXA2 staining
pattern between tumors and normal mucosae (P >
0.05). Membranous staining was predominant in both
fields. There was a significant difference between
tumors and normal mucosae in terms of staining
intensity (P = 0.000). Tumors stained more intensely
than normal mucosae. There was diffuse staining in
the tumoral areas, while normal mucosae generally
only showed staining in the basal and suprabasal
regions (Figures 1 and 2). Epithelial cells stained more
weakly as they matured.
There were no statistically significant differences
in the ANXA2 staining pattern intensity and score
between cases with and without lymph node
involvement (P > 0.05).
There was a significant relationship between the
degree of differentiation and the ANXA2 staining
pattern (P = 0.001). Well-differentiated tumors
showed 100% membranous staining, while the rate
549
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Figure 1. The basal and suprabasal layers are mostly stained
membranously with ANXA2 in normal epithelium
(400×, immunoperoxidase).
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Figure 2. All yields are diffusely stained positive in tumors with
ANXA2 (100×, immunoperoxidase). High-power
microscopic appearance of the ANXA2 membranous
staining pattern is seen in the left upper corner (200×,
immunoperoxidase).

In the tumor ANXA2 staining intensity

was 66.7% for moderately differentiated and 33.3% for
poorly differentiated tumors. There was a significant
relationship between the degree of differentiation and
ANXA2 staining intensity (P = 0.001). ANXA2
staining intensity increased as the tumors
differentiated, as can be seen in Table 1 (Figure 3).
There was also a significant relationship between the
degree of differentiation and ANXA2 staining score
(P = 0). Staining became more diffuse as tumor
differentiation increased.

3
staining intensity

Figure 3. ANXA2 staining in poorly differentiated HNSSC.
ANXA2-negative tumor islands are surrounded by
ANXA2-positive
inflamed
cells
(100×,
immunoperoxidase).

2

1

0

well

moderate

poorly

Tumor differentiation

Table 1. The relationship between ANXA2 staining and
differentiation in HNSCC.
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There was no relationship between ANXA2
staining intensity or score, and tumor size (P > 0.05);
however, we did observe a significant relationship
between the staining pattern and tumor size (P =
0.026). The percentage of membranous staining
decreased as tumor size increased (Table 2).
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Table 2. ANXA2 membranous immunostaining pattern according to tumor size.
Tumor size

The percentage of the
ANXA2 membranous staining pattern

≤ 2 cm
(n = 19 cases)

> 2 and < 4 cm
(n = 19 cases)

> 4 cm
(n = 5 cases)

94.7%
(18 cases)

84.2%
(16 cases)

40.0%
(2 cases)

Expression of Annexin 7 in normal epithelium
and tumors
There was no difference between the tumoral and
normal mucosal staining patterns with ANXA7 (P >
0.05). The tumors showed diffuse staining, while
normal epithelium had staining in the lower half. As
with ANXA2, the epithelial cells showed decreased
staining as they matured.
We did not observe statistically significant
differences in ANXA7 staining pattern, intensity, or
amount between cases with and without lymph node
involvement (P > 0.05).
There was an almost significant relationship
between the degree of differentiation and ANXA7
staining pattern (P = 0.056). There was membranous
staining in 84% of well-differentiated tumors and the
rate decreased as tumor differentiation decreased.
Membranous staining was present in 60% of
moderately differentiated tumors and in only 33.3%
of poorly differentiated tumors. There was no

significant relationship between the degree of
differentiation and ANXA7 staining intensity or score
(P > 0.05).
There was no relationship between the score or
intensity of the ANXA7 staining pattern and tumor
size (P > 0.05); however, there was a significant linear
relationship between ANXA2 and ANXA7. ANXA7
produced less intense staining than ANXA2 did, but
similar cases showed similar staining (Figures 4 and
5).
When HNSCC was divided into 2 categories
according to developmental pattern (expansile and
infiltrative) we observed a significant difference in the
ANXA7 staining pattern between the 2 groups (P =
0.001) (Table 3).
Expression of Annexin 11 in normal epithelium
and tumor
Analysis of the expression pattern and intensity of
ANXA11 in normal epithelium and tumor areas in 43
cases is presented in Table 4.

Figures 4 and 5. ANXA7 produced less intense staining than ANXA2, but similar cases show similar staining (200×, immunoperoxidase).
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Table 3. ANXA7 staining pattern according to HNSCC growth pattern.
ANX A7

No staining

Cytoplasmic

Membranous

Total

Infiltrative

3
27.30%

4
36.40%

4
36.40%

11
100%

Expansile

0
0%

5
15.60%

27
84.40%

32
100%

Table 4. ANX A11 staining pattern and intensity in HNSCC.
Pattern

Severity

ANX A11
Nuclear

Cytoplasmic Membranous

+
Intensity

++
Intensity

+++
Intensity

Staining
none

Normal
epithelium

23
53.50%

10
23.30%

5
11.60%

19
44.20%

14
32.60%

5
11.60%

5
11.60%

Tumor

24
55.80%

10
23.30%

5
11.60%

5
11.60%

7
16.30%

25
58.10%

6
14.00%

Staining score in the tumoral areas was
significantly higher than in normal epithelium.
We did not observe a difference in the ANXA11
staining pattern between tumors and normal mucosae
(P > 0.05). Tumors frequently stained nuclear, as did
normal epithelium (Figure 6). There was a significant
difference between tumors and mucosae, in terms of

staining intensity (P = 0.05). Tumors stained more
intensely than normal epithelium, as with ANXA2.
There was diffuse staining in the tumoral areas, while
epithelium showed staining of the lower half.
There was no statistically significant difference in
ANXA11 staining pattern, intensity, or amount
between cases with and without lymph node
involvement (P > 0.05). A significant relationship was
not observed between the degree of differentiation,
and ANXA11 staining pattern, intensity, or amount
(P > 0.05). We did not observe a relationship between
ANXA11 staining pattern, amount, or intensity, and
tumor size (P > 0.05).
Discussion

Figure 6. Microscopic appearance of ANXA11 mostly nuclear
staining in HNSCC (200×, immunoperoxidase).
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Despite extensive research, many of the
complicated biological events in HNSCC remain
unclear. Understanding the related molecular changes
may be an important step in understanding the
diagnosis, ensuring treatment and prevention of the
disorder.
We
observed
different
immunohistochemical expressions of ANXA2,
ANXA7, and ANXA11 in normal mucosal epithelium
(squamous epithelium) and HNSCC. These
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differences indicate that the relevant proteins may
play a role in the carcinogenesis of HNSCC.
Another study reported more dominant ANXA1
staining in the cell membrane in normal oral mucosa
and increased membranous staining, together with
decreased nuclear staining in oral squamous cell
carcinoma cases (12). A similar study reported
decreased ANXA1 expression with decreasing
differentiation in normal squamous epithelium,
dysplasia, and invasive carcinoma spectrum of the
head and neck region (13). A 2007 study
immunohistochemically defined ANX antibody
expression in premalignant and invasive squamous
cell lesions of the pharynx and larynx (10). It
investigated the potential role of ANXA2 in these
tumors by evaluating normal epithelium as well. In
that study paraffin blocks from 9 patients with
premalignant lesions and 21 HNSCC patients were
immunohistochemically stained with ANXA2, and a
significant correlation between the expression of this
protein and histopathological grade was observed.
ANXA2 expression was higher in well-differentiated
tumors than in those that were moderately or poorly
differentiated. ANXA2 expression was observed in
almost all well-differentiated tumors, whereas most
cells did not show staining in poorly differentiated
tumors. Staining was most dense in the welldifferentiated and keratinized areas of welldifferentiated tumors. We obtained results that were
similar, and ANXA2 expression was strongest in welldifferentiated tumors and the most differentiated
areas of the tumors. There was weak or no staining in
poorly differentiated cases. We did not observe the
same significant relationship between ANXA2
immunohistochemical expression and tumor
invasiveness as Rodrigo Tapia et al. reported (10). A
study on esophageal squamous cell carcinomas
reported increased ANXA2 expression associated
with moderately and poorly differentiated tumors
other than head and neck carcinomas (14).
Srivastava et al. reported an increased incidence of
tumor in mice with the ANXA7 gene removed
(knockout) (15). Studies on prostate cancer have
shown ANXA7 to be a candidate tumor suppressor
gene (16); however, there is no definite consensus that
ANXA7 is a tumor-suppressor gene. There are no
reports on the expression of ANXA7 in HNSCC. We
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observed a significant linear relationship between
ANXA2 and ANXA7, but the relationship between
the ANXA7 expression pattern and the degree of
differentiation was on the borderline of significant.
We think this may have been due to the low number
of tumors that stained with ‘+++’ intensity as a result
of weaker staining with ANXA7 and that a larger
series may provide more statistically significant data
regarding the relationship between ANXA7 and
tumor differentiation. Despite the lack of statistical
significance for staining intensity, HNSCC cases
showed diffuse staining in contrast to the staining
limited to the lower half in normal epithelium. The
selective staining in the most differentiated areas of
the tumors, similar to that of ANXA2 but less intense,
was also noted. ANXA7 and ANXA2 showed the
staining pattern seen with adhesion molecules, such
as E-cadherin, in the normal epithelium and tumor
areas of HNSCC. This is also supported by the
relationship we observed between the tumor growth
pattern and ANXA7. This finding indicates that
ANXA7 may be useful for determining tumor
invasiveness and prognosis. A 2008 study showed loss
of ANXA7 expression in gastric signet ring carcinoma
and mucinous adenocarcinoma, while its expression
was preserved in glandular and nodular gastric
carcinomas (17). The tumors in which they observed
expression loss were less differentiated gastric tumors
or infiltrative-type tumors. A previous study reported
a relationship between decreased ANXA7 expression
and high invasive potential of tumors (18). The
significant difference between tumors with expansile
or infiltrative growth, together with the ANXA7
staining pattern in the present study and the
decreased expression in the infiltrative pattern,
supports a possible role for ANXA7 in tumor
invasiveness, as reported in the mentioned studies. We
did not observe a relationship between the growth
pattern of HNSCC and ANXA2. These results
indicate that ANXA2 and ANXA7 are similar, but
have different roles, even though they are both related
to HNSCC differentiation and have similar staining
features. ANXA7 plays a role in local invasion of
HNSCC, in contrast to ANXA2.
It was reported that gastric cancer cases are
associated with weak ANXA7 expression and distant
metastases (17). We did not find a relationship
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between ANXA7, and lymph node metastasis, tumor
size, or tumor stage. This may have been due to the
small number of cases, and the lack of data regarding
follow-up and the development of metastases, as the
patients had been operated on recently.
ANXA11 is a nuclear protein during the
interphase and then displays a well-regulated
localization pattern from the prophase to cytokinesis,
the later stages of the cell cycle. This indicates a role
for ANXA11 in the terminal phase of cytokinesis
(19,20). We observed nuclear staining in the basal and
suprabasal layers in the epithelium, with 25%-75%
distribution in ~60% of the HNSCC cases.
Proteomic and immunohistochemical analyses
have shown increased ANXA11 expression in
colorectal carcinoma tumor areas, as compared with
normal epithelium, as well as a relationship between
this increase and increased tumor stage (21). As with
ANXA7, there are no data on the expression of
ANXA11 in HNSCC. We did not observe a significant
relationship between HNSCC differentiation and
ANXA11, as we did with ANXA2; however, the
increased expression of ANXA11 in tumors, as
compared to normal epithelium, indicates a role in
carcinogenesis for these proteins as well.

Turk J Med Sci

Previous studies of HNSCC have reported a
relationship between stage and ANXA2 expression.
We did not observe a statistically significant
relationship between the intensity and amount of
ANXA2 expression, and tumor size or lymph node
metastasis status; as tumor size increased the ANXA7
membranous staining rate decreased and welldifferentiated tumors showed increased membranous
staining.
Annexins are markers that show tumor typespecific expression characteristics and are indicative
of the diagnosis and prognosis (22). Although there
has been extensive research on some annexins, the
role of most in tumor development remains unclear
(23). Staining distribution was different in normal
epithelium and tumors; therefore, we think that these
markers can be used in the differential diagnosis.
ANXA2 and ANXA7 expression is related to
differentiation, and we think that ANXA2 and
ANXA7 may be used to determine HNSCC
prognosis. We would like to note that they may also be
used in the differential diagnosis of preliminary
HNSCC lesions (dysplasias), based on the observed
staining difference in normal epithelium, which has
also been reported in other studies.
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